Table 3.
Lifetime prevalence of overall CAM use among patients with ESRD on MHD by patient characteristics (%)a.
| No CAM use (n = 35) | Any CAM use (n = 54) |
|
|---|---|---|
| Percentage of all patients | 39 | 61 |
| Age (years)b | ||
| 18–34 | 9 | 4 |
| 35–49 | 20 | 15 |
| 50–64 | 20 | 52 |
| 65–79 | 31 | 22 |
| ≥80 | 20 | 7 |
| Female | 37 | 54 |
| Race | ||
| White | 29 | 30 |
| Black | 63 | 63 |
| Other | 9 | 8 |
| Dialysis vintage (years) | ||
| <1 | 23 | 30 |
| 1–4 | 34 | 44 |
| 5–9 | 34 | 17 |
| ≥10 | 9 | 9 |
| Principal ESRD diagnosis | ||
| Diabetes mellitus | 49 | 61 |
| Hypertension | 20 | 9 |
| Glomerulonephritis | 9 | 11 |
| HIVAN | 6 | 6 |
| Other | 17 | 13 |
| Employment status | (n = 34) | (n = 51) |
| Employed full or part time | 12 | 18 |
| Retired | 53 | 24 |
| Disabled | 35 | 59 |
| Education level | (n = 27) | (n = 41) |
| Postgraduate degree | 7 | 12 |
| College degree | 4 | 15 |
| Vocational or high school degree | 70 | 61 |
| Grade school or lower | 19 | 12 |
| BMI ± SD | (n = 23) 30.3 ± 10.7 | (n = 41) 26.3 ± 6.3 |
CAM: complementary and alternative medicine; ESRD: end-stage renal disease; MHD: maintenance hemodialysis; HIVAN: HIV-associated nephropathy; and BMI ± SD: body mass index ± standard deviation.
aFigures are percentages of patients based on the number (n) in each group.
bWithin group differences significant between any CAM use or CAM modality and no CAM use with P < 0.05 by Fisher's exact test.